IRF1 and cancer: IRF1, a classical downstream target of IFNγ, functions as a transcription factor critical in mediating IFNγ-induced anti-proliferation, apoptosis, invasion inhibition, and antitumor immunity in cancer [[41], [42], [43], [44], [45]].